UCLA bioengineers invent novel soft and flexible self-powered bioelectronic device
A team of bioengineers at the UCLA Samueli School of Engineering has invented a novel soft and flexible self-powered bioelectronic device.
Source: news-medical.net
Page 12 - Jun Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jun Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jun Chen Today - Breaking & Trending Today
UCLA team develop flexible self-powered bioelectronic device
Bioengineers at UCLA have developed a soft and flexible self-powered bioelectronic device that converts body motions into electricity.
Source: theengineer.co.uk
Researchers Develop Novel Wearable Magnetoelastic Generators
A group of bioengineers from the Samueli School of Engineering, University of California-Los Angeles have developed a novel soft and flexible self-powered bioelectric device.
Source: azom.com
上半年融资70.7亿元 中原高速如何拓展多元化融资渠道？ _ 东方财富网
8月20日，河南中原高速公路股份有限公司(以下简称中原高速)发布2021年半年报。营业收入、净利润分别较去年同期大幅增长。业绩增长的主要原因是，去年上半年受新冠疫情防控期间免收车辆通行费政策影响，收入大幅下降，因此，今年上半年通行费收入同比大幅度上涨。上半年，中原高速通过多渠道融资，合理置换中短期贷款，实现融资70.7亿元，偿还债务76.34亿元，资产负债率下降至73.55%。
Source: eastmoney.com
Effectiveness Similar for First-Line ACE Inhibitors, ARBs in HTN
Jul 26, 2021 MONDAY, July 26, 2021 (HealthDay News) — For patients with hypertension initiating treatment, effectiveness is comparable for angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), but ARBs have a better safety profile, according to a study published online July 26 in Hypertension. RuiJun Chen, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues compared the real-world effectiveness and safety of ACE inhibitors versus ARBs in first-line treatment of hypertension. All patients with hypertension initiating ...
Source: physiciansweekly.com